Biotin (B7)
biotin · vitamin B7 · vitamin H · D-biotin
Snapshot
| Indications | Contraindications |
|---|---|
Biotin (vitamin B7) is a water-soluble vitamin that works as a cofactor for carboxylases in fatty acid, glucose, and amino acid metabolism1. Supplementation restores that cofactor supply, as in biotinidase deficiency, where lifelong oral biotin prevents neurological and skin symptoms1. It is also taken for hair, nail, and skin health1, and has been tested at pharmacologic doses in progressive multiple sclerosis6. Pregnancy, lactation, chronic alcohol exposure, and long-term anticonvulsant therapy carry the highest risk of low status1.
Hair, nail, and skin support rests on case reports and small uncontrolled studies, and a dermatology review found the evidence insufficient to recommend biotin1, 7. In progressive multiple sclerosis, a 2016 trial reported disability reversal in a subset of patients, but a larger phase 3 trial found no significant improvement6, 8. A 2025 laboratory study found elevated serum biotin in hemodialysis and intensive care patients, and newer immunoassay reagents tolerating higher biotin concentrations9. Products list biotin as single-ingredient, B-complex, or multivitamin formulations; see Form comparison1.
The most consequential caution is analytic: biotin interferes with immunoassays built on biotin-streptavidin binding, producing falsely high or low results, including thyroid and troponin tests. Per the National Institutes of Health Office of Dietary Supplements fact sheet, the Food and Drug Administration advises providers to ask patients about biotin when laboratory results do not match the clinical picture1.
Last updated October 16, 2026. Read how we make monographs.
In the full monograph
63 sources, 51 studies
- When to useThe situations practitioners use it for, each with the reason and the study behind it.
- SafetyWho should avoid it, who needs extra care, and the side effects reported in studies.
- InteractionsThe medicines and supplements it interacts with, the effect of each, and what labeling says to watch.
- Protocol notesThe doses used in studies, how and when they were taken, and how the forms on the market compare.
- How it worksWhat it is and how it works in the body, in plain terms.
- Published studiesThe studies behind each use, popular claims checked against them, and trials still under way.
- Word of mouthWhat patients and practitioners report online, kept separate from the clinical evidence.
- Clinical perspectiveA closing read of where the evidence is solid, where it is thin, and what has not been studied.
Sources
- 1NIH ODSods.od.nih.govNIH Office of Dietary Supplements — Fact Sheet for Health Professionals
- 2Evaluation of biophysical skin parameters and hair changes in patients with acne vulgaris treated with isotretinoin, and the effect of biotin use on these parameters.pubmed.ncbi.nlm.nih.govAksac, Bilgili, Yavuz et al. · International journal of dermatology · 2021 · Pubmed
- 3Influence of biotin intervention on glycemic control and lipid profile in patients with type 2 diabetes mellitus: A systematic review and meta-analysis.pubmed.ncbi.nlm.nih.govZhang, Ding, Fan et al. · Frontiers in nutrition · 2022 · Pubmed
- 4Improving neuropathy scores in type 2 diabetic patients using micronutrients supplementation.pubmed.ncbi.nlm.nih.govFarvid, Homayouni, Amiri et al. · Diabetes research and clinical practice · 2011 · Pubmed
- 5US product labelsdsld.od.nih.govWarnings printed on US dietary supplement labels with this ingredient, from the NIH Office of Dietary Supplements' Dietary Supplement Label Database (DSLD). Manufacturers' precautions, not evidence of harm
- 6MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study.pubmed.ncbi.nlm.nih.govTourbah, Lebrun-Frenay, Edan et al. · Multiple sclerosis (Houndmills, Basingstoke, England) · 2016 · Pubmed
- 7Dietary supplements in dermatology: A review of the evidence for zinc, biotin, vitamin D, nicotinamide, and Polypodium.pubmed.ncbi.nlm.nih.govThompson, Kim · Journal of the American Academy of Dermatology · 2021 · Pubmed
- 8Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trial.pubmed.ncbi.nlm.nih.govCree, Cutter, Wolinsky et al. · The Lancet. Neurology · 2020 · Pubmed
- 9Biotin interference in routine clinical immunoassays.pubmed.ncbi.nlm.nih.govChiu, Jhan, Yan et al. · Practical laboratory medicine · 2025 · Pubmed